Model
Edge
4D Molecular Therapeutics
0001833453
Filing Type
4
Filing Date
5/22/2024
Updated
5/23/24, 5:10 PM
Filing
4
Earnings Release
Exhibits
4
Statement of Changes in Beneficial Ownership